BCL2L1 and neoplasm: TBX5 and YES-associated protein 1 (YAP1) form a complex with β-catenin, which localizes and activates BCL2 Like 1 (BCL2L1) and Baculoviral IAP Repeat Containing 5 (BIRC5), thereby enhancing the anti-apoptotic effect on tumor cells [79].